When older, overweight people lose belly fat from exercise, a chemical called chemerin in their blood also drops—so chemerin might be a sign that their fat tissue is getting healthier.
Scientific Claim
In older obese adults, reductions in plasma chemerin following 12 weeks of aerobic exercise are significantly correlated with decreases in visceral fat mass (r=0.50, P=0.009), suggesting chemerin may serve as a biomarker of adipose tissue remodeling.
Original Statement
“Lower chemerin concentrations after training were also associated with decreased total cholesterol (r=0.38, P=0.04, Figure 3a) and triglyceride concentrations (r=0.36, P=0.05, Figure 3b). The reduction in chemerin was significantly correlated with decreased visceral fat mass (r=0.50, P=0.009, Figure 2c).”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study shows correlation, not causation. Authors imply chemerin 'reflects' remodeling, but the design cannot determine directionality or mechanism.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether targeted reduction of visceral fat (via surgery or drugs) independently lowers chemerin, regardless of exercise.
Whether targeted reduction of visceral fat (via surgery or drugs) independently lowers chemerin, regardless of exercise.
What This Would Prove
Whether targeted reduction of visceral fat (via surgery or drugs) independently lowers chemerin, regardless of exercise.
Ideal Study Design
A 12-week RCT in 80 older obese adults comparing visceral fat reduction via bariatric surgery versus aerobic exercise versus diet-only, measuring chemerin, adipose tissue gene expression, and systemic inflammation as primary outcomes.
Limitation: Surgical intervention introduces confounding factors like rapid metabolic shifts and hormonal changes.
Prospective Cohort StudyLevel 2bWhether baseline chemerin predicts future visceral fat accumulation or response to lifestyle intervention.
Whether baseline chemerin predicts future visceral fat accumulation or response to lifestyle intervention.
What This Would Prove
Whether baseline chemerin predicts future visceral fat accumulation or response to lifestyle intervention.
Ideal Study Design
A 3-year prospective cohort of 300+ older adults with obesity tracking chemerin, serial CT scans of visceral fat, and lifestyle changes, adjusting for diet, activity, and medications.
Limitation: Cannot prove chemerin drives fat loss or is merely a byproduct.
In Vitro Cell StudyLevel 5Whether chemerin expression in human adipocytes is directly regulated by adipocyte size or inflammatory signals.
Whether chemerin expression in human adipocytes is directly regulated by adipocyte size or inflammatory signals.
What This Would Prove
Whether chemerin expression in human adipocytes is directly regulated by adipocyte size or inflammatory signals.
Ideal Study Design
Human subcutaneous and visceral adipocytes from obese donors cultured under conditions mimicking fat loss (low insulin, low FFA) or inflammation (TNF-α), measuring chemerin mRNA and secretion.
Limitation: Does not reflect systemic hormonal or neural regulation of adipose tissue.
Evidence from Studies
Supporting (1)
Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults
In older, obese adults, doing aerobic exercise for 12 weeks lowered a fat-related protein called chemerin, and the more their belly fat decreased, the more chemerin dropped — showing chemerin could be a useful sign of fat loss.